Monday, Sep 28, 2026

"granules-india-limited"

Granules India Limited receives final approval from USFDA for its new drug

Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients aged six years and older, as well as for Moderate to Severe Binge Eating Disorder (BED) in adults

Latest News

DJ operator dies while operating public address system in Siddipet

1 minute ago
Despair, suicides among weavers return to Sircilla town over past 3 years

9 minutes ago
Harish Rao targets Congress govt on protests at Secretariat over pending dues

9 minutes ago
No More Chemo Party held for children completing chemotherapy in Hyderabad

22 minutes ago
Banjara JAC wants public toilets built at Yellandu cross roads in Kothagudem

25 minutes ago
WPL 2027: MI part ways with G Kamalini, release six players

29 minutes ago
Hyderabad’s walima-style dinners offer a taste of Muslim wedding traditions

30 minutes ago
Man arrested for murdering sibling following land disputes in Mancherial

35 minutes ago